Journal of Medicinal Chemistry · 2010 · 35 citations · 30 references
MedicineMedicinal ChemistryPharmacologyBiochemical PharmacologyCell SignalingMolecular PharmacologyDrug-receptor InteractionsG Protein-coupled Receptor SignalingLigand BindingReceptor BindingReceptor PharmacologyReceptor-ligand InteractionsAgonist ActivityG Protein-coupled Receptor ActivationG-protein-coupled ReceptorsPyrimidine AnalogsPyrimidine AnaloguesPyrimidine ChemistryReceptor-ligand SelectivitySelectivity
The P2Y(6) receptor is a cytoprotective G-protein-coupled receptor (GPCR) activated by UDP (EC(50) = 0.30 microM). We compared and combined modifications to enhance P2Y(6) receptor agonist selectivity, including ribose ring constraint, 5-iodo and 4-alkyloxyimino modifications, and phosphate modifications such as alpha,beta-methylene and extension of the terminal phosphate group into gamma-esters of UTP analogues. The conformationally constrained (S)-methanocarba-UDP is a full agonist (EC(50) = 0.042 microM). 4-Methoxyimino modification of pyrimidine enhanced P2Y(6), preserved P2Y(2) and P2Y(4), and abolished P2Y(14) receptor potency, in the appropriate nucleotide. N(4)-Benzyloxy-CDP (15, MRS2964) and N(4)-methoxy-Cp(3)U (23, MRS2957) were potent, selective P2Y(6) receptor agonists (EC(50) of 0.026 and 0.012 microM, respectively). A hydrophobic binding region near the nucleobase was explored with receptor modeling and docking. UTP-gamma-aryl and cycloalkyl phosphoesters displayed only intermediate P2Y(6) receptor potency but had enhanced stability in acid and cell membranes. UTP-glucose was inactive, but its (S)-methanocarba analogue and N(4)-methoxycytidine 5'-triphospho-gamma-[1]glucose were active (EC(50) of 2.47 and 0.18 microM, respectively). Thus, the potency, selectivity, and stability of pyrimidine nucleotides as P2Y(6) receptor agonists may be enhanced by modest structural changes.
30
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis
Schuichi Koizumi, Yukari Shigemoto‐Mogami, Kaoru Nasu‐Tada et al. · Nature · 2007 · 808 citations
Benjamin R. Yerxa, Juan Sabater, C. William Davis et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 150 citations